SCHEMBL5340648

SCHEMBL5340648

O=C(Cl)c1cccn2c(-c3ccccc3-c3ccc(Cl)cc3)cnc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 9/20 0.49
NPC1 O15118 8/20 0.49
SMN1; SMN2 Q16637 7/20 0.49
MAPT P10636 6/20 0.49
ALDH1A1 P00352 5/20 0.49
KDM4E B2RXH2 4/20 0.49
MEN1 O00255 3/20 0.49
KMT2A Q03164 3/20 0.49
NFKB1 P19838 2/20 0.49
NFKB2 Q00653 2/20 0.49
RELA Q04206 2/20 0.49
MKNK1 Q9BUB5 1/20 0.44
TDP1 Q9NUW8 1/20 0.41
SLC6A4 P31645 1/20 0.40
SLC6A3 Q01959 1/20 0.40
IDO1 P14902 3/20 0.39
L3MBTL1 Q9Y468 1/20 0.38
MAPK1 P28482 1/20 0.37
ALDH1A2 O94788 1/20 0.36
ALDH1A3 P47895 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5478856 0.90 RAB9A (0.49) RAB9ANPC1SMN1; SMN2MAPTALDH1A1
SCHEMBL28640320 0.72 SLC6A3 (0.64) SMN1; SMN2ALDH1A1MEN1KMT2ATDP1
SCHEMBL5340645 0.69 AKT1 (0.54) KDM4EL3MBTL1LMNA
SCHEMBL7306815 0.66 NPC1 (0.56) RAB9ANPC1SMN1; SMN2MAPTALDH1A1
SCHEMBL4779545 0.66 RAB9A (1.00) RAB9ANPC1SMN1; SMN2MAPTALDH1A1
SCHEMBL14014080 0.66 KDM4E (0.58) RAB9ANPC1SMN1; SMN2MAPTALDH1A1
SCHEMBL1880394 0.65 IDO1 (0.53) RAB9ANPC1SMN1; SMN2MAPTALDH1A1
SCHEMBL7317057 0.64 RAB9A (0.44) RAB9ANPC1SMN1; SMN2MAPTALDH1A1
SCHEMBL10631889 0.64 SLC6A4 (0.66) SMN1; SMN2MEN1KMT2ATDP1SLC6A4
SCHEMBL9090176 0.63 KDM4E (0.47) RAB9ANPC1SMN1; SMN2MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007086080-A2 NOVEL IMIDAZO[1,2-a]PYRIDINE CANNABINOID RECEPTOR LIGANDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM GLENMARK PHARMACEUTICALS LIMITED (IN) 2007-08-02 WO disclosed